James Bucher
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
James B. Bucher currently works at Harpoon Therapeutics, Inc., as Chief Legal Officer from 2023 and Zentalis Pharmaceuticals, Inc., as Secretary & Chief Legal Officer from 2025.
Mr. Bucher also formerly worked at Exelixis, Inc., as Secretary & Vice President-Corporate Legal Affairs from 2013 to 2014, Shearman & Sterling LLP, as Partner from 2001 to 2007, Lundbeck Seattle BioPharmaceuticals, Inc., as Executive Vice President & General Counsel, and Climb Bio, Inc., as Executive Vice President & General Counsel.
Mr. Bucher received his undergraduate degree from Colgate University and graduate degree from Emory University School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Conseiller Juridique Général | 26/12/2023 |
| ZENTALIS PHARMACEUTICALS, INC. | Conseiller Juridique Général | 18/09/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| EXELIXIS, INC. | Conseiller Juridique Général | 01/01/2014 |
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | 01/01/2007 |
| CLIMB BIO, INC. | Conseiller Juridique Général | - |
| ALDER BIOPHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Emory University School of Law
Emory University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national